|
|
|
Volumn 59, Issue 11, 2013, Pages 1003-1007
|
|
SAVOR-TIMI 53 - Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus;SAVOR-TINI53 - Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
a
|
|
Author keywords
Diabetes mellitus; DPP 4 inhibitors; Heart failure; Mortality; Saxagliptin
|
|
Indexed keywords
PLACEBO;
SAXAGLIPTIN;
ADAMANTANE;
DIPEPTIDE;
ANGINA PECTORIS;
ARTICLE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR MORTALITY;
CARDIOVASCULAR RISK;
CEREBROVASCULAR ACCIDENT;
CONTROLLED STUDY;
DIABETES CONTROL;
DIABETIC PATIENT;
HEART FAILURE;
HEART INFARCTION;
HEART MUSCLE REVASCULARIZATION;
HIGH RISK PATIENT;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OUTCOME ASSESSMENT;
PANCREATITIS;
PATIENT MONITORING;
RANDOMIZED CONTROLLED TRIAL;
AGED;
ANALOGS AND DERIVATIVES;
CLINICAL TRIAL;
COMPLICATION;
CROSS-SECTIONAL STUDY;
CZECH REPUBLIC;
DIABETES MELLITUS, TYPE 2;
FEMALE;
HEART DISEASES;
MALE;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
MYOCARDIAL INFARCTION;
SURVIVAL;
ADAMANTANE;
AGED;
CROSS-SECTIONAL STUDIES;
CZECH REPUBLIC;
DIABETES MELLITUS, TYPE 2;
DIPEPTIDES;
FEMALE;
HEART DISEASES;
HEART FAILURE;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
SURVIVAL ANALYSIS;
|
|
EID: 84889577594
PISSN: 0042773X
EISSN: 18017592
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (15)
|
|
References (3)
|
